Understanding how USP15 loss precisely impacts HSC and cancer cell maintenance and modulates their damage response may help to identify combinatorial treatment that affect leukemia self-renewal while sparing normal HSC from the side effects of conventional chemotherapy. The gene discussed is USP15; the disease is leukemia.